Pictet Asset Management (UK)’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Pictet Asset Management (UK)’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-208,729	Closed	-$2.91M	–	912
2017 Q4	$2.91M	Buy	208,729 +67,700	+48%	+$915K	0.01%	755
2017 Q3	$2.61M	Sell	141,029 -14,900	-10%	-$249K	0.01%	761
2017 Q2	$2.26M	Buy	155,929 +6,900	+5%	+$105K	0.01%	769
2017 Q1	$1.99M	Buy	149,029 +21,100	+16%	+$330K	0.01%	775
2016 Q4	$1.93M	Sell	127,929 -106,800	-45%	-$1.41M	0.01%	753
2016 Q3	$2.74M	Buy	234,729 +24,800	+12%	+$292K	0.01%	689
2016 Q2	$2.47M	Buy	209,929 +18,929	+10%	+$195K	0.01%	720
2016 Q1	$1.6M	Hold	191,000	–	–	0.01%	718
2015 Q4	$2.83M	Sell	191,000 -53,400	-22%	-$894K	0.01%	670
2015 Q3	$4.01M	Sell	244,400 -48,200	-16%	-$987K	0.02%	602
2015 Q2	$6.36M	Buy	292,600 +192,437	+192%	+$3.83M	0.03%	532
2015 Q1	$1.75M	Buy	100,163 +45,863	+84%	+$596K	0.01%	764
2014 Q4	$654K	Buy	54,300 +3,500	+7%	+$40K	﹤0.01%	823
2014 Q3	$576K	Buy	50,800 +9,900	+24%	+$113K	﹤0.01%	817
2014 Q2	$494K	Buy	40,900 +8,300	+25%	+$98K	﹤0.01%	830
2014 Q1	$380K	Buy	32,600 +2,500	+8%	+$42.3K	﹤0.01%	829
2013 Q4	$532K	Sell	30,100 -12,400	-29%	-$208K	﹤0.01%	812
2013 Q3	$612K	Buy	42,500 +5,900	+16%	+$90.3K	﹤0.01%	800
2013 Q2	$551K	Buy	+36,600	New	+$483K	﹤0.01%	798

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pictet Asset Management (UK)'s MNTA Position: Q1 2018 in Review

Pictet Asset Management (UK) sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q1 2018, closing a stake of 208,729 shares — an estimated $2.91M sold.

Pictet Asset Management (UK) first reported a position in MNTA in Q2 2013 and held it in 19 quarters. The position peaked at $6.36M in Q2 2015. 163 funds tracked by Wall St. Rank hold MNTA as of Q1 2018.

Pictet Asset Management (UK) reported no remaining Momenta Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Pictet Asset Management (UK) sold 208,729 Momenta Pharmaceuticals, Inc. shares in Q1 2018, an estimated $2.91M.
Pictet Asset Management (UK) first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 19 quarters.
Pictet Asset Management (UK)'s Momenta Pharmaceuticals, Inc. position peaked at $6.36M in Q2 2015.
163 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2018.

Based on Pictet Asset Management (UK)'s 13F filing for Q1 2018, filed 25 Apr 2018.